☰

Ebru Erbay, Ph.D. - Publications

Affiliations: 
2004 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
Molecular Biology, Cell Biology
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Yildirim Z, Baboo S, Hamid SM, Dogan AE, Tufanli O, Robichaud S, Emerton C, Diedrich JK, Vatandaslar H, Nikolos F, Gu Y, Iwawaki T, Tarling E, Ouimet M, Nelson DL, ... ... Erbay E, et al. Intercepting IRE1 kinase-FMRP signaling prevents atherosclerosis progression. Embo Molecular Medicine. e15344. PMID 35191199 DOI: 10.15252/emmm.202115344  0.316
2019 Onat UI, Yildirim AD, Tufanli Ö, Çimen I, Kocatürk B, Veli Z, Hamid SM, Shimada K, Chen S, Sin J, Shah PK, Gottlieb RA, Arditi M, Erbay E. Intercepting the Lipid-Induced Integrated Stress Response Reduces Atherosclerosis. Journal of the American College of Cardiology. 73: 1149-1169. PMID 30871699 DOI: 10.1016/J.Jacc.2018.12.055  0.362
2018 Tumurkhuu G, Dagvadorj J, Porritt RA, Crother TR, Shimada K, Tarling EJ, Erbay E, Arditi M, Chen S. Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis. Cell Metabolism. PMID 29937375 DOI: 10.1016/J.Cmet.2018.05.027  0.33
2018 Koelwyn GJ, Corr EM, Erbay E, Moore KJ. Regulation of macrophage immunometabolism in atherosclerosis. Nature Immunology. PMID 29777212 DOI: 10.1038/S41590-018-0113-3  0.385
2018 Chen S, Shimada K, Crother TR, Erbay E, Shah PK, Arditi M. Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis. Journal of the American College of Cardiology. 71: 1553-1570. PMID 29622163 DOI: 10.1016/J.Jacc.2018.01.072  0.386
2017 Tufanli O, Telkoparan Akillilar P, Acosta-Alvear D, Kocaturk B, Onat UI, Hamid SM, Çimen I, Walter P, Weber C, Erbay E. Targeting IRE1 with small molecules counteracts progression of atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 28137856 DOI: 10.1073/Pnas.1621188114  0.442
2016 Çimen I, Kocatürk B, Koyuncu S, Tufanlı Ö, Onat UI, Yıldırım AD, Apaydın O, Demirsoy Ş, Aykut ZG, Nguyen UT, Watkins SM, Hotamışlıgil GS, Erbay E. Prevention of atherosclerosis by bioactive palmitoleate through suppression of organelle stress and inflammasome activation. Science Translational Medicine. 8: 358ra126. PMID 27683551 DOI: 10.1126/Scitranslmed.Aaf9087  0.41
2016 Babaev VR, Yeung M, Erbay E, Ding L, Zhang Y, May JM, Fazio S, Hotamisligil GS, Linton MF. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27102962 DOI: 10.1161/Atvbaha.116.307580  0.416
2016 Nadir M, Tufanlı Ö, Erbay E, Atalay A. Identification of differentially expressed microRNAs during lipotoxic endoplasmic reticulum stress in RAW264.7 macrophages / RAW264.7 makrofajlarında lipotoksik endoplazmik retikulum stres sürecinde ifadesi değişen mikroRNAların tanımlanması Turkish Journal of Biochemistry. 41. DOI: 10.1515/Tjb-2016-0031  0.378
2015 Erbay E. Fine-tuning inflammasome activity with a small molecule or ketogenic diet Science Translational Medicine. 7. DOI: 10.1126/Scitranslmed.Aaa9862  0.338
2015 Erbay E. Therapeutic treasure hunt in the myeloid secretome Science Translational Medicine. 7. DOI: 10.1126/Scitranslmed.Aaa5552  0.327
2014 Erbay E. ER-Mitochondrial Communication Gets Stressful Science Translational Medicine. 6: 213-267. DOI: 10.1126/Scitranslmed.Aaa3453  0.333
2014 Erbay E. BETing on the Therapeutic Potential of Super Enhancers Science Translational Medicine. 6. DOI: 10.1126/Scitranslmed.Aaa1225  0.356
2014 Erbay E. Sumo Wrestling Atherosclerosis Science Translational Medicine. 6. DOI: 10.1126/Scitranslmed.3010406  0.332
2014 Erbay E. Stress (In)Flames Atherosclerosis Science Translational Medicine. 6. DOI: 10.1126/Scitranslmed.3010113  0.313
2014 Erbay E. Bacteria-Driven Atherosclerosis Science Translational Medicine. 6. DOI: 10.1126/Scitranslmed.3009306  0.311
2011 Babaev VR, Runner RP, Fan D, Ding L, Zhang Y, Tao H, Erbay E, Görgün CZ, Fazio S, Hotamisligil GS, Linton MF. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 1283-90. PMID 21474828 DOI: 10.1161/Atvbaha.111.225839  0.372
2010 Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, Snitow ME, Fazio S, Wiest MM, Watkins SM, Linton MF, Hotamisligil GS. Erratum: Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis Nature Medicine. 16: 237-237. DOI: 10.1038/Nm0210-237C  0.339
2009 Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, Snitow ME, Fazio S, Wiest MM, Watkins SM, Linton MF, Hotamisligil GS. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nature Medicine. 15: 1383-91. PMID 19966778 DOI: 10.1038/Nm.2067  0.398
2008 Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nature Reviews. Immunology. 8: 923-34. PMID 19029988 DOI: 10.1038/Nri2449  0.326
2007 Erbay E, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome. Current Atherosclerosis Reports. 9: 222-9. PMID 18241617 DOI: 10.1007/S11883-007-0023-6  0.391
2006 Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 6970-5. PMID 16641093 DOI: 10.1073/Pnas.0602178103  0.34
2005 Park IH, Erbay E, Nuzzi P, Chen J. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Experimental Cell Research. 309: 211-9. PMID 15963500 DOI: 10.1016/J.Yexcr.2005.05.017  0.554
2003 Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. The Journal of Cell Biology. 163: 931-6. PMID 14662739 DOI: 10.1083/Jcb.200307158  0.536
2001 Erbay E, Chen J. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. The Journal of Biological Chemistry. 276: 36079-82. PMID 11500483 DOI: 10.1074/Jbc.C100406200  0.43
Show low-probability matches.